As of Oct 09
| -0.01 / -0.51%|
The 3 analysts offering 12-month price forecasts for Synta Pharmaceuticals Corp have a median target of 9.00, with a high estimate of 13.00 and a low estimate of 6.00. The median estimate represents a +356.85% increase from the last price of 1.97.
The current consensus among 4 polled investment analysts is to Buy stock in Synta Pharmaceuticals Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.